Novo Nordisk (NVO, NOVO-B.CO) said first-quarter sales of its first-to-market weight-loss drug Wegovy were 17.36bn Danish crowns (£1.97bn/$2.64bn), declining 13% from the previous quarter. Revenues ...

U.S. stock futures were up in early European trading following through on moves after the bell Tuesday on optimism around U.S.-China trade talks, while most European markets were down on EU tariff ...

Not long ago the largest company by market capitalization in Europe, the evolution of the weight loss medicine market has ...

Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Obesity drugmaker Novo Nordisk cut its sales forecasts on Wednesday for ...